News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Treco Douglas A
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/09/2023 |
4
| Treco Douglas A (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns:
| Granted 13,000 options to buy
@ $62.59, valued at
$813.7k
|
|
04/04/2023 |
4
| Treco Douglas A (CEO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns:
| Granted 800,000 options to buy
@ $0 Granted 100,000 restricted stock units
@ $0 |
|
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/24/2020 |
4
| Treco Douglas A (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns:
| Granted 9,367 options to buy
@ $16, valued at
$149.9k
|
|
06/15/2020 |
4
| Treco Douglas A (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns:
| Granted 30,000 options to buy
@ $59.7, valued at
$1.8M
|
|
04/03/2020 |
4
| Treco Douglas A (President and CEO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns:
| Disposed/sold 234,707 shares
@ $48, valued at
$11.3M
Disposed/sold 139,371 options to buy
@ $2.87, valued at
$400k
Disposed/sold 241,460 options to buy
@ $2.87, valued at
$693k
Disposed/sold 164,285 options to buy
@ $5.6, valued at
$920k
Disposed/sold 225,000 options to buy
@ $16.64, valued at
$3.7M
Disposed/sold 125,000 options to buy
@ $7.33, valued at
$916.3k
Disposed/sold 311,000 options to buy
@ $21, valued at
$6.5M
Disposed/sold 20,833 restricted stock units
@ $0 |
|
02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2018 |
4
| Treco Douglas A (President and CEO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns:
| Granted 125,000 options to buy
@ $7.33, valued at
$916.3k
Granted 62,500 restricted stock units
@ $0 |
|
02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|